Skip to main content
Top
Published in: Abdominal Radiology 6/2012

Open Access 01-12-2012

A computer-assisted model for detection of MRI signs of Crohn’s disease activity: future or fiction?

Authors: Jeroen A.W. Tielbeek, Frans M. Vos, Jaap Stoker

Published in: Abdominal Radiology | Issue 6/2012

Login to get access

Abstract

Magnetic resonance imaging is increasingly used for abdominal evaluation and is more and more considered as the optimal imaging technique for detection of mural inflammation in patients with Crohn’s disease. Grading the disease activity is important in daily clinical practice to monitor the medical treatment and is assessed by evaluating different magnetic resonance imaging features. Unfortunately, only moderate interobserver agreement is reported for most of the subjective features and should be improved. A computer-assisted model for automatic detection of abnormalities, ability to grade disease severity, and thereby influence clinical disease management based on magnetic resonance imaging is missing. Recent techniques have focused on semi-automated methods for classification and segmentation of the bowel and also on objective measurement of bowel wall enhancement using absolute T1-values or dynamic contrast-enhanced imaging. This article reviews the available computerized techniques, as well as preferred developments.
Literature
1.
go back to reference Florie J, Wasser MNJM, Arts-Cieslik K, et al. (2006) Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease. AJR 186:1384–1392PubMedCrossRef Florie J, Wasser MNJM, Arts-Cieslik K, et al. (2006) Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease. AJR 186:1384–1392PubMedCrossRef
2.
go back to reference Koh DM, Miao Y, Chinn RJS, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease. AJR 177:1325–1332PubMed Koh DM, Miao Y, Chinn RJS, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease. AJR 177:1325–1332PubMed
3.
go back to reference Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB (1993) Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 17:73–78PubMedCrossRef Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB (1993) Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 17:73–78PubMedCrossRef
4.
go back to reference Shoenut JP, Semelka RC, Magro CM, et al. (1994) Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 19:31–35PubMedCrossRef Shoenut JP, Semelka RC, Magro CM, et al. (1994) Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 19:31–35PubMedCrossRef
5.
go back to reference Maccioni F, Viscido A, Broglia L, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef Maccioni F, Viscido A, Broglia L, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25:219–228PubMedCrossRef
6.
go back to reference Maccioni F, Viscido A, Marini M, Caprilli R (2002) MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging 27:384–393PubMedCrossRef Maccioni F, Viscido A, Marini M, Caprilli R (2002) MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging 27:384–393PubMedCrossRef
7.
go back to reference Punwani S, Rodriguez-Justo M, Bainbridge A, et al. (2009) Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252:712–720PubMedCrossRef Punwani S, Rodriguez-Justo M, Bainbridge A, et al. (2009) Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 252:712–720PubMedCrossRef
8.
go back to reference Fletcher JG, Fidler JL, Bruining DH, Huprich JE (2011) New concepts in intestinal imaging for inflammatory bowel diseases. Gastroenterology 140:1795–1806PubMedCrossRef Fletcher JG, Fidler JL, Bruining DH, Huprich JE (2011) New concepts in intestinal imaging for inflammatory bowel diseases. Gastroenterology 140:1795–1806PubMedCrossRef
9.
go back to reference Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 247:64–79PubMedCrossRef Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 247:64–79PubMedCrossRef
11.
go back to reference Jensen MD, Ormstrup T, Vagn-Hansen C, Østergaard L, Rafaelsen SR (2011) Interobserver and intermodality agreement for detection of small bowel Crohn’s disease with MR enterography and CT enterography. Inflamm Bowel Dis 17:1081–1088PubMedCrossRef Jensen MD, Ormstrup T, Vagn-Hansen C, Østergaard L, Rafaelsen SR (2011) Interobserver and intermodality agreement for detection of small bowel Crohn’s disease with MR enterography and CT enterography. Inflamm Bowel Dis 17:1081–1088PubMedCrossRef
12.
13.
go back to reference Florie J, Horsthuis K, Hommes DW, et al. (2005) Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn’s disease. Clin Gastroenterol Hepatol 3:1221–1228PubMedCrossRef Florie J, Horsthuis K, Hommes DW, et al. (2005) Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn’s disease. Clin Gastroenterol Hepatol 3:1221–1228PubMedCrossRef
14.
go back to reference van Gemert-Horsthuis K, Florie J, Hommes DW, et al. (2006) Feasibility of evaluating Crohn’s disease activity at 3.0 Tesla. J Magn Reson Imaging 24:340–348PubMedCrossRef van Gemert-Horsthuis K, Florie J, Hommes DW, et al. (2006) Feasibility of evaluating Crohn’s disease activity at 3.0 Tesla. J Magn Reson Imaging 24:340–348PubMedCrossRef
15.
go back to reference Sharman A, Zealley IA, Greenhalgh R, Bassett P, Taylor SA (2009) MRI of small bowel Crohn’s disease: determining the reproducibility of bowel wall gadolinium enhancement measurements. Eur Radiol 19:1960–1967PubMedCrossRef Sharman A, Zealley IA, Greenhalgh R, Bassett P, Taylor SA (2009) MRI of small bowel Crohn’s disease: determining the reproducibility of bowel wall gadolinium enhancement measurements. Eur Radiol 19:1960–1967PubMedCrossRef
16.
go back to reference Gourtsoyiannis NC, Papanikolaou N, Karantanas A (2006) Magnetic resonance imaging evaluation of small intestinal Crohn’s disease. Best Pract Res Clin Gastroenterol 20:137–156PubMedCrossRef Gourtsoyiannis NC, Papanikolaou N, Karantanas A (2006) Magnetic resonance imaging evaluation of small intestinal Crohn’s disease. Best Pract Res Clin Gastroenterol 20:137–156PubMedCrossRef
17.
go back to reference Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384PubMedCrossRef Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA (2010) MR enterographic manifestations of small bowel Crohn disease. Radiographics 30:367–384PubMedCrossRef
18.
go back to reference Horsthuis K, Bipat S, Stokkers PCF, Stoker J (2009) Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review. Eur Radiol 19:1450–1460PubMedCrossRef Horsthuis K, Bipat S, Stokkers PCF, Stoker J (2009) Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review. Eur Radiol 19:1450–1460PubMedCrossRef
19.
go back to reference Rimola J, Rodriguez S, García-Bosch O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120PubMedCrossRef Rimola J, Rodriguez S, García-Bosch O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120PubMedCrossRef
20.
go back to reference Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:1759–1768PubMedCrossRef Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17:1759–1768PubMedCrossRef
21.
go back to reference Vos FM, van Gelder RE, Serlie IWO, et al. (2003) Three-dimensional display modes for CT colonography: conventional 3D virtual colonoscopy versus unfolded cube projection. Radiology 228:878–885PubMedCrossRef Vos FM, van Gelder RE, Serlie IWO, et al. (2003) Three-dimensional display modes for CT colonography: conventional 3D virtual colonoscopy versus unfolded cube projection. Radiology 228:878–885PubMedCrossRef
22.
go back to reference Serlie IWO, de Vries AH, van Vliet LJ, et al. (2008) Lesion conspicuity and efficiency of CT colonography with electronic cleansing based on a three-material transition model. AJR 191:1493–1502PubMedCrossRef Serlie IWO, de Vries AH, van Vliet LJ, et al. (2008) Lesion conspicuity and efficiency of CT colonography with electronic cleansing based on a three-material transition model. AJR 191:1493–1502PubMedCrossRef
23.
go back to reference Bielen D, Kiss G (2007) Computer-aided detection for CT colonography: update. Abdom imaging 32:571–581PubMedCrossRef Bielen D, Kiss G (2007) Computer-aided detection for CT colonography: update. Abdom imaging 32:571–581PubMedCrossRef
25.
go back to reference Pupillo VA, Di Cesare E, Frieri G, et al. (2007) Assessment of inflammatory activity in Crohn’s disease by means of dynamic contrast-enhanced MRI. Radiol Med 112:798–809PubMedCrossRef Pupillo VA, Di Cesare E, Frieri G, et al. (2007) Assessment of inflammatory activity in Crohn’s disease by means of dynamic contrast-enhanced MRI. Radiol Med 112:798–809PubMedCrossRef
26.
go back to reference Gowland P, Mansfield P, Bullock P, et al. (1992) Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 26:241–258PubMedCrossRef Gowland P, Mansfield P, Bullock P, et al. (1992) Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 26:241–258PubMedCrossRef
27.
go back to reference Horsthuis K, Nederveen AJ, de Feiter M-W, et al. (2009) Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn’s disease: a feasibility study. J Magn Reson Imaging 29:488–493PubMedCrossRef Horsthuis K, Nederveen AJ, de Feiter M-W, et al. (2009) Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn’s disease: a feasibility study. J Magn Reson Imaging 29:488–493PubMedCrossRef
28.
go back to reference Taylor SA, Rodriguez-justo M, Bainbridge A, et al. (2009) Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination—pilot study. Radiology 251(2):369–379PubMedCrossRef Taylor SA, Rodriguez-justo M, Bainbridge A, et al. (2009) Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination—pilot study. Radiology 251(2):369–379PubMedCrossRef
29.
go back to reference Horsthuis K, Lavini C, Bipat S, Stokkers PCF, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387PubMedCrossRef Horsthuis K, Lavini C, Bipat S, Stokkers PCF, Stoker J (2009) Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251:380–387PubMedCrossRef
30.
go back to reference Kuß a , Gensel M, Meyer B, Dercksen VJ, Prohaska S (2010) Effective techniques to visualize filament-surface relationships. Comput Graph Forum 29:1003–1012CrossRef Kuß a , Gensel M, Meyer B, Dercksen VJ, Prohaska S (2010) Effective techniques to visualize filament-surface relationships. Comput Graph Forum 29:1003–1012CrossRef
31.
32.
go back to reference Best WR, Becktel JM, Singleton JW, Kern F (1976) Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 70:439–444PubMed Best WR, Becktel JM, Singleton JW, Kern F (1976) Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 70:439–444PubMed
33.
go back to reference Houts PS, Doak CC, Doak LG, Loscalzo MJ (2006) The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence. Patient Educ Couns 61:173–190PubMedCrossRef Houts PS, Doak CC, Doak LG, Loscalzo MJ (2006) The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence. Patient Educ Couns 61:173–190PubMedCrossRef
35.
go back to reference Ritter F, Hansen C, Dicken V, et al. (2006) Real-time illustration of vascular structures. IEEE Trans Vis Comput Graph 12:877–884PubMedCrossRef Ritter F, Hansen C, Dicken V, et al. (2006) Real-time illustration of vascular structures. IEEE Trans Vis Comput Graph 12:877–884PubMedCrossRef
Metadata
Title
A computer-assisted model for detection of MRI signs of Crohn’s disease activity: future or fiction?
Authors
Jeroen A.W. Tielbeek
Frans M. Vos
Jaap Stoker
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 6/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9822-x

Other articles of this Issue 6/2012

Abdominal Radiology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.